Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PVA embolization with or without bleomycin for giant liver hemangioma
IRCT20191105045343N1Phase 3Completed
- Sponsor
- Shahed University
- Start
- Jan 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label trial of bleomycin in hepatic hemangioma (2 arms), sponsored by Shahed University. Primary endpoints: Size of liver hemangioma lesions, Liver enzyme level and 1 more. Started Jan 2020; status: completed.
02
Drugs
bleomycin
03
Conditions
hepatic hemangioma
Beyond the preview
Go deeper on IRCT20191105045343N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20191105045343N1.